Northern Trust Corp Galectin Therapeutics Inc Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Galectin Therapeutics Inc stock. As of the latest transaction made, Northern Trust Corp holds 234,280 shares of GALT stock, worth $623,184. This represents 0.0% of its overall portfolio holdings.

Number of Shares

234,280

Previous 126,974 84.51%

Holding current value

$623,184

Previous $286,000 125.17%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$2.04 - $2.86 $218,904 - $306,895	107,306 Added 84.51%	234,280 $644,000
Q2 2024 Aug 14, 2024	BUY	$2.13 - $4.2 $55,002 - $108,456	25,823 Added 25.53%	126,974 $286,000
Q1 2024 May 14, 2024	BUY	$1.6 - $2.44 $206 - $314	129 Added 0.13%	101,151 $241,000
Q4 2023 Feb 13, 2024	SELL	$1.6 - $2.18 $1,507 - $2,053	-942 Reduced 0.92%	101,022 $167,000
Q2 2023 Aug 11, 2023	BUY	$1.32 - $2.08 $9,511 - $14,988	7,206 Added 7.6%	101,964 $146,000
Q1 2023 May 15, 2023	BUY	$1.1 - $2.4 $10,884 - $23,748	9,895 Added 11.66%	94,758 $198,000
Q4 2022 Feb 13, 2023	SELL	$1.03 - $1.66 $401 - $647	-390 Reduced 0.46%	84,863 $95,000
Q3 2022 Nov 14, 2022	SELL	$1.31 - $2.48 $6,036 - $11,427	-4,608 Reduced 5.13%	85,253 $139,000
Q2 2022 Aug 12, 2022	SELL	$1.19 - $1.74 $4,375 - $6,397	-3,677 Reduced 3.93%	89,861 $118,000
Q1 2022 May 13, 2022	SELL	$1.61 - $2.31 $724 - $1,039	-450 Reduced 0.48%	93,538 $150,000
Q4 2021 Feb 08, 2022	BUY	$2.07 - $3.8 $10,697 - $19,638	5,168 Added 5.82%	93,988 $194,000
Q3 2021 Nov 15, 2021	SELL	$2.59 - $4.15 $19,295 - $30,917	-7,450 Reduced 7.74%	88,820 $345,000
Q2 2021 Aug 13, 2021	SELL	$2.07 - $5.1 $672,404 - $1.66 Million	-324,833 Reduced 77.14%	96,270 $309,000
Q1 2021 May 12, 2021	SELL	$1.96 - $2.57 $62,433 - $81,864	-31,854 Reduced 7.03%	421,103 $913,000
Q4 2020 Feb 11, 2021	SELL	$2.24 - $2.87 $29,135 - $37,330	-13,007 Reduced 2.79%	452,957 $1.01 Million
Q3 2020 Nov 16, 2020	SELL	$2.53 - $3.64 $71,814 - $103,321	-28,385 Reduced 5.74%	465,964 $1.25 Million
Q2 2020 Aug 14, 2020	SELL	$1.66 - $3.15 $37,657 - $71,457	-22,685 Reduced 4.39%	494,349 $1.51 Million
Q1 2020 May 14, 2020	BUY	$1.51 - $3.0 $40,350 - $80,166	26,722 Added 5.45%	517,034 $1.01 Million
Q4 2019 Feb 14, 2020	BUY	$2.79 - $4.32 $2,438 - $3,775	874 Added 0.18%	490,312 $1.4 Million
Q3 2019 Nov 13, 2019	BUY	$3.0 - $4.05 $1.07 Million - $1.44 Million	355,322 Added 264.94%	489,438 $1.8 Million
Q2 2019 Aug 13, 2019	BUY	$3.61 - $5.0 $160,085 - $221,725	44,345 Added 49.4%	134,116 $556,000
Q1 2019 May 13, 2019	BUY	$3.86 - $6.02 $10,958 - $17,090	2,839 Added 3.27%	89,771 $458,000
Q4 2018 Feb 12, 2019	SELL	$3.43 - $5.74 $3,268 - $5,470	-953 Reduced 1.08%	86,932 $298,000
Q3 2018 Nov 14, 2018	BUY	$3.68 - $6.93 $4,662 - $8,780	1,267 Added 1.46%	87,885 $529,000
Q2 2018 Aug 14, 2018	BUY	$3.16 - $9.16 $23,263 - $67,435	7,362 Added 9.29%	86,618 $551,000
Q1 2018 May 09, 2018	SELL	$3.78 - $5.97 $16,677 - $26,339	-4,412 Reduced 5.27%	79,256 $376,000
Q4 2017 Feb 14, 2018	BUY	$1.54 - $3.34 $4,510 - $9,782	2,929 Added 3.63%	83,668 $279,000
Q3 2017 Nov 13, 2017	BUY	$1.67 - $2.3 $134,834 - $185,699	80,739	80,739 $173,000

Others Institutions Holding GALT

# of Institutions

Shares Held

9.44M

Call Options Held

1.16M

Put Options Held

1.98M

View Full List

About GALECTIN THERAPEUTICS INC

Ticker GALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,426,000
Market Cap $158M
Description
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...

More about GALT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Galectin Therapeutics Inc Transaction History